42 development and commercialization of diagnostics for genetic diseases and disorders; development and commercialization of technology to improve clinical outcomes of individuals with genetic diseases and disorders; development and commercialization of diagnostics for identifying genetic diseases and disorders; genome sequencing services; clinical rapid whole genome sequencing test to enable the prevention, diagnosis and treatment of genetic diseases and disorders; development and commercialization of technology that provides clinical guidance; software platform for data analysis, data management, data storage, data interpretation, and report generation, all in the field of genetics and genetic testing; clinical decision support technology to assist in the translation of complex genomic sequencing for use in treatment plans by healthcare providers